PLTH:CA:CNSX-Planet 13 Holdings Inc (CAD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 0.79

Change

0.00 (0.00)%

Market Cap

USD 0.26B

Volume

5.91K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States. It owns, manufactures, and sells cannabis products in the form of chocolates, gummies, sparkling beverages, vapes and concentrates, and flowers under the TRENDI, Leaf and Vine, Dreamland, HaHa, Lifestyles, and Medizin brand names. The company also operates licensed cannabis dispensaries; and non-cannabis retail merchandise store and event space, as well as owns and operates Trece Eatery + Spirits, a coffee shop and pizzeria restaurant. In addition, it provides consultation, education, and convenience services. The company is headquartered in Las Vegas, Nevada. Address: 2548 West Desert Inn Road, Las Vegas, NV, United States, 89109

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
GTII:CA Green Thumb Industries Inc

-0.04 (-0.25%)

USD 3.28B
TRUL:CA Trulieve Cannabis Corp

-0.07 (-0.43%)

USD 2.92B
CL:CA Cresco Labs Inc

-0.02 (-0.90%)

USD 0.77B
AYR-A:CA Ayr Wellness Inc

+0.01 (+0.41%)

USD 0.28B
GRIN:CA Grown Rogue International Inc

+0.03 (+3.23%)

USD 0.21B
AAWH-U:CA Ascend Wellness Holdings Inc.

-0.02 (-2.50%)

USD 0.17B
JUSH:CA Jushi Holdings Inc

+0.06 (+9.23%)

USD 0.13B
IAN:CA iAnthus Capital Holdings Inc

+0.01 (+50.00%)

USD 0.10B
MRMD:CA MariMed Inc.

N/A

USD 0.09B
FFNT:CA 4Front Ventures Corp

N/A

USD 0.06B

ETFs Containing PLTH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.14% 54% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.14% 54% F 59% D-
Trailing 12 Months  
Capital Gain -27.52% 44% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -27.52% 44% F 50% F
Trailing 5 Years  
Capital Gain -65.35% 65% D 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -65.35% 65% D 41% F
Average Annual (5 Year Horizon)  
Capital Gain 26.11% N/A N/A 80% B-
Dividend Return 26.11% N/A N/A 80% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 140.69% N/A N/A 19% F
Risk Adjusted Return 18.56% N/A N/A 77% C+
Market Capitalization 0.26B 94% A 99% N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector